Expression of cytokine mRNA in human melanoma tissues

[1]  G. Murphy,et al.  Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine , 1994, Cancer Immunology, Immunotherapy.

[2]  M. Matsuda,et al.  Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression , 1994, The Journal of experimental medicine.

[3]  P. Hersey,et al.  Production of IL‐10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma , 1994, International journal of cancer.

[4]  K. Matsushima,et al.  Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. , 1993, Journal of immunology.

[5]  M. Chen,et al.  Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expression , 1993, International journal of cancer.

[6]  O. Bagasra,et al.  Polymerase chain reaction in situ: intracellular amplification and detection of HIV-1 proviral DNA and other specific genes. , 1993, Journal of immunological methods.

[7]  E. Halapi,et al.  Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Lee,et al.  Changes in expression of CD45R during the development of Th1 and Th2 cell lines , 1992, European journal of immunology.

[9]  G. Tosato,et al.  IL-10 inhibits human T cell proliferation and IL-2 production. , 1992, Journal of immunology.

[10]  P. Scott.  IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. , 1991, Journal of immunology.

[11]  G. Murphy,et al.  Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases. , 1991, Cancer research.

[12]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[13]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[14]  G. Stamp,et al.  Investigation of cytokine gene expression in human colorectal cancer. , 1990, Cancer research.

[15]  O. Stutman,et al.  Tumor growth in vivo selects for resistance to tumor necrosis factor. , 1989, Journal of immunology.

[16]  R. Coffman,et al.  Role of Cytokines and CD4+ T‐Cell Subsets in the Regulation of Parasite Immunity and Disease , 1989, Immunological reviews.

[17]  D. Berd,et al.  Depletion of T-cells with the CD4+CD45R+ phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma. , 1989, Cancer research.

[18]  A. Stoppacciaro,et al.  Limiting dilution analysis of TNF producing cells in C3H/HeJ mice. , 1988, Journal of immunology.

[19]  H. Maguire,et al.  Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. , 1986, Cancer research.

[20]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.